World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 4021552

Number of visits today: 32286

Number of downloads: 2484673

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 2 (2308)

Contents Volume 2 Issue 2 February 10, 2011

Editorial

Exploiting the homologous recombination DNA repair network for targeted cancer therapy

Guang Peng, Shiaw-Yih Lin

World J Clin Oncol 2(2):73-79. Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.73

Abstract (1864) | Core Tip (1334) | Full Article (HTML) (17453) | Figures (1-4) (4490) | Tables (1-1) (1071) | Full Article (PDF)-694K (1767) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (5) | Cite | (0) | (0) | (0) | (24781) | (40) | Open

Tyrosine kinase inhibitors: Multi-targeted or single-targeted?

Fleur Broekman, Elisa Giovannetti, Godefridus J Peters

World J Clin Oncol 2(2):80-93. Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.80

Abstract (1849) | Core Tip (1587) | Full Article (HTML) (20364) | Figures (1-1) (1096) | Tables (1-5) (981) | Full Article (PDF)-957K (3146) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (6) | Cite | (0) | (0) | (0) | (25587) | (199) | Open

Topic Highlight

Surgical strategy for bile duct cancer: Advances and current limitations

Nobuhisa Akamatsu, Yasuhiko Sugawara, Daijo Hashimoto

World J Clin Oncol 2(2):94-107. Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.94

Abstract (1762) | Core Tip (1356) | Full Article (HTML) (15695) | Figures (1-2) (1466) | Tables (1-3) (592) | Full Article (PDF)-1087K (1020) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (1) | Cite | (0) | (0) | (0) | (18773) | (53) | Open

Interventional endoscopic ultrasonography for pancreatic cancer

Kazuo Hara, Kenji Yamao, Nobumasa Mizuno, Susumu Hijioka, Akira Sawaki, Masahiro Tajika, Hiroki Kawai, Shinya Kondo, Yasuhiro Shimizu, Yasumasa Niwa

World J Clin Oncol 2(2):108-114. Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.108

Abstract (1581) | Core Tip (1469) | Full Article (HTML) (3713) | Figures (1-4) (525) | Full Article (PDF)-1115K (528) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (0) | Cite | (0) | (0) | (0) | (4766) | (12) | Open

Review

Glucan-immunostimulant, adjuvant, potential drug

Vaclav Vetvicka

World J Clin Oncol 2(2):115-119. Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.115

Abstract (1514) | Core Tip (1053) | Full Article (HTML) (14030) | Figures (1-1) (736) | Full Article (PDF)-621K (623) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (0) | Cite | (0) | (0) | (0) | (15389) | (89) | Open

Oncogenic activity of MCM7 transforming cluster

Jian-Hua Luo

World J Clin Oncol 2(2):120-124. Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.120

Abstract (1399) | Core Tip (954) | Full Article (HTML) (5093) | Figures (1-1) (518) | Full Article (PDF)-624K (445) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (29) | Cite | (0) | (0) | (0) | (6056) | (34) | Open

Current status of therapy for breast cancer worldwide and in Japan

Youngjin Park, Tomoaki Kitahara, Ryuichi Takagi, Ryoji Kato

World J Clin Oncol 2(2):125-134. Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.125

Abstract (1393) | Core Tip (957) | Full Article (HTML) (7214) | Figures (1-14) (550) | Tables (1-3) (559) | Full Article (PDF)-1125K (720) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Similar Articles (212) | Cite | (0) | (0) | (0) | (9043) | (11) | Open

Write to the Help Desk

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.